(VIANEWS) – Devon Energy (DVN), World Wrestling Entertainment (WWE), Dow Chemical Company (DOW) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Devon Energy (DVN)

146.5% sales growth and 5.06% return on equity

Devon Energy Corporation, an independent energy company, primarily engages in the exploration, development, and production of oil, natural gas, and natural gas liquids in the United States.

Devon Energy’s sales growth this year is anticipated to be 124.3% and 10.7% for next year.

Year-on-year quarterly revenue growth grew by 294.3%, now sitting on 7.9B for the twelve trailing months.

Volume

Today’s last reported volume for Devon Energy is 14342600 which is 3.67% above its average volume of 13834600.

Devon Energy’s sales growth for the next quarter is 146.5%. The company’s growth estimates for the present quarter and the next is 2325% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.06%.

Volatility

Devon Energy’s last day, last week, and last month’s current intraday variation average was 3.29%, 1.64%, and 2.29%, respectively.

Devon Energy’s highest amplitude of average volatility was 2.77% (day), 6.66% (last week), and 5.67% (last month), respectively.

Devon Energy’s Stock Yearly Top and Bottom Value

Devon Energy’s stock is valued at $57.52 at 20:22 EST, way higher than its 52-week high of $44.79.

Devon Energy’s Moving Average

Devon Energy’s value is way above its 50-day moving average of $39.29 and way above its 200-day moving average of $30.48.

2. World Wrestling Entertainment (WWE)

25.8% sales growth and 46.86% return on equity

World Wrestling Entertainment, Inc., an integrated media and entertainment company, engages in the sports entertainment business in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

World Wrestling Entertainment’s sales growth this year is expected to be 13.8% and 7.6% for next year.

Year-on-year quarterly revenue growth grew by 30.3%, now sitting on 1.1B for the twelve trailing months.

Volume

Today’s last reported volume for World Wrestling Entertainment is 443392 which is 27.07% below its average volume of 608050.

World Wrestling Entertainment’s sales growth for the next quarter is 25.8%. The company’s growth estimates for the ongoing quarter and the next is 21.6% and 73.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.86%.

Volatility

World Wrestling Entertainment’s last day, last week, and last month’s current intraday variation average was 1.14%, 0.94%, and 1.21%, respectively.

World Wrestling Entertainment’s highest amplitude of average volatility was 2.33% (day), 2.40% (last week), and 2.92% (last month), respectively.

World Wrestling Entertainment’s Stock Yearly Top and Bottom Value

World Wrestling Entertainment’s stock is valued at $55.96 at 20:22 EST, way under its 52-week high of $70.72 and way above its 52-week low of $46.81.

World Wrestling Entertainment’s Moving Average

World Wrestling Entertainment’s worth is higher than its 50-day moving average of $53.56 and higher than its 200-day moving average of $54.06.

Previous days news about World Wrestling Entertainment(WWE)

  • According to Benzinga on Tuesday, 15 March, "Scott Hall, who starred for the World Wrestling Entertainment Inc (NYSE: WWE) and World Championship Wrestling in the 1990s and 2000s, died Monday night at the age of 63, according to the company."

3. Dow Chemical Company (DOW)

21.3% sales growth and 28.66% return on equity

Dow Inc. provides various materials science solutions for consumer care, infrastructure, and packaging markets in the United States, Canada, Europe, the Middle East, Africa, India, the Asia Pacific, and Latin America.

Dow Chemical Company’s sales growth this year is expected to be 37.1% and a negative 3.1% for next year.

Year-on-year quarterly revenue growth grew by 66.2%, now sitting on 46.19B for the twelve trailing months.

Volume

Today’s last reported volume for Dow Chemical Company is 9241680 which is 58.85% above its average volume of 5817640.

Dow Chemical Company’s sales growth for the next quarter is 21.3%. The company’s growth estimates for the present quarter and the next is 408% and 132.1%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.66%.

Volatility

Dow Chemical Company’s last day, last week, and last month’s current intraday variation average was 0.46%, 1.39%, and 1.37%, respectively.

Dow Chemical Company’s highest amplitude of average volatility was 2.66% (day), 2.87% (last week), and 2.57% (last month), respectively.

Dow Chemical Company’s Stock Yearly Top and Bottom Value

Dow Chemical Company’s stock is valued at $62.84 at 20:22 EST, way under its 52-week high of $71.38 and way above its 52-week low of $50.20.

Dow Chemical Company’s Moving Average

Dow Chemical Company’s value is above its 50-day moving average of $58.20 and higher than its 200-day moving average of $62.48.

4. Brown & Brown (BRO)

15.9% sales growth and 14.77% return on equity

Brown & Brown, Inc. markets and sells insurance products and services in the United States, Bermuda, Canada, Cayman Islands, Ireland, and the United Kingdom.

Brown & Brown’s sales growth this year is anticipated to be 9.1% and 7.9% for next year.

Year-on-year quarterly revenue growth grew by 15.1%, now sitting on 3.05B for the twelve trailing months.

Volume

Today’s last reported volume for Brown & Brown is 787571 which is 55.07% below its average volume of 1753250.

Brown & Brown’s sales growth for the next quarter is 15.9%. The company’s growth estimates for the present quarter and the next is 7.1% and 10.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.77%.

Volatility

Brown & Brown’s last day, last week, and last month’s current intraday variation average was 3.94%, 3.32%, and 1.90%, respectively.

Brown & Brown’s highest amplitude of average volatility was 4.24% (day), 4.02% (last week), and 2.99% (last month), respectively.

Brown & Brown’s Stock Yearly Top and Bottom Value

Brown & Brown’s stock is valued at $62.95 at 20:22 EST, way under its 52-week high of $70.75 and way higher than its 52-week low of $44.54.

Brown & Brown’s Moving Average

Brown & Brown’s worth is under its 50-day moving average of $66.82 and above its 200-day moving average of $60.61.

5. Humana (HUM)

11% sales growth and 28.04% return on equity

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States.

Humana’s sales growth this year is anticipated to be 9.2% and 10.6% for next year.

Year-on-year quarterly revenue growth grew by 9.2%, now sitting on 78.89B for the twelve trailing months.

Volume

Today’s last reported volume for Humana is 1140650 which is 12.92% below its average volume of 1309930.

Humana’s sales growth for the next quarter is 11%. The company’s growth estimates for the ongoing quarter and the next is 51.6% and 201.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.04%.

Volatility

Humana’s last day, last week, and last month’s current intraday variation average was 1.22%, 1.34%, and 1.18%, respectively.

Humana’s highest amplitude of average volatility was 3.09% (day), 2.75% (last week), and 2.52% (last month), respectively.

Humana’s Stock Yearly Top and Bottom Value

Humana’s stock is valued at $441.09 at 20:22 EST, below its 52-week high of $475.44 and way above its 52-week low of $370.22.

Humana’s Moving Average

Humana’s value is above its 50-day moving average of $430.57 and above its 200-day moving average of $432.82.

Previous days news about Humana(HUM)

  • According to Bloomberg Quint on Tuesday, 15 March, "Enrollment in Medicare Advantage plans has doubled over the past decade to cover nearly half of Medicare’s 64 million beneficiaries, fetching billions for large insurers including UnitedHealth Group Inc., Humana Inc. and CVS Health Corp.’s Aetna unit that have bet heavily on the business."

6. Investors Bancorp (ISBC)

11% sales growth and 10.65% return on equity

Investors Bancorp, Inc. operates as the bank holding company for Investors Bank that provides various banking products and services to individuals and businesses in the United States.

Investors Bancorp’s sales growth this year is anticipated to be 6.3% and 6.1% for next year.

Year-on-year quarterly revenue growth grew by 15.7%, now sitting on 882.02M for the twelve trailing months.

Volume

Today’s last reported volume for Investors Bancorp is 2241450 which is 7.21% below its average volume of 2415650.

Investors Bancorp’s sales growth for the next quarter is 11%. The company’s growth estimates for the current quarter and the next is 14.3% and 3.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.65%.

Volatility

Investors Bancorp’s last day, last week, and last month’s current intraday variation average was 1.02%, 2.40%, and 1.52%, respectively.

Investors Bancorp’s highest amplitude of average volatility was 3.00% (day), 3.66% (last week), and 2.67% (last month), respectively.

Investors Bancorp’s Stock Yearly Top and Bottom Value

Investors Bancorp’s stock is valued at $16.74 at 20:22 EST, below its 52-week high of $17.67 and way above its 52-week low of $12.60.

Investors Bancorp’s Moving Average

Investors Bancorp’s value is above its 50-day moving average of $16.31 and way above its 200-day moving average of $15.08.

7. Hope Bancorp (HOPE)

7% sales growth and 9.87% return on equity

Hope Bancorp, Inc. operates as the bank holding company for Bank of Hope that provides banking services for small and medium-sized businesses, and individuals in the United States.

Hope Bancorp’s sales growth this year is anticipated to be 7.5% and 9% for next year.

Year-on-year quarterly revenue growth grew by 38.4%, now sitting on 568.56M for the twelve trailing months.

Volume

Today’s last reported volume for Hope Bancorp is 720217 which is 15.48% below its average volume of 852156.

Hope Bancorp’s sales growth for the next quarter is 7%. The company’s growth estimates for the present quarter and the next is 11.4% and negative -4.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.87%.

Volatility

Hope Bancorp’s last day, last week, and last month’s current intraday variation average was 3.61%, 2.79%, and 1.59%, respectively.

Hope Bancorp’s highest amplitude of average volatility was 2.57% (day), 3.60% (last week), and 2.65% (last month), respectively.

Hope Bancorp’s Stock Yearly Top and Bottom Value

Hope Bancorp’s stock is valued at $16.07 at 20:22 EST, below its 52-week high of $17.68 and way above its 52-week low of $12.48.

Hope Bancorp’s Moving Average

Hope Bancorp’s worth is under its 50-day moving average of $16.23 and higher than its 200-day moving average of $14.81.